BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Front Immunol 2020;11:1280. [PMID: 32849491 DOI: 10.3389/fimmu.2020.01280] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Cai J, Wen J, Li X, Yu Y, Zhang L, Han Q, Wei Z, Ma Y, Ying F, Xu X, Li W, Yang Q, Sun S, He X, Cai L, Xiao H, Wang Z. Boosting ferroptosis via abplatin(iv) for treatment of platinum-resistant recurrent ovarian cancer. Nano Today 2022;44:101459. [DOI: 10.1016/j.nantod.2022.101459] [Reference Citation Analysis]
2 Cioce M, Pulito C, Strano S, Blandino G, Fazio VM. Metformin: Metabolic Rewiring Faces Tumor Heterogeneity. Cells 2020;9:E2439. [PMID: 33182253 DOI: 10.3390/cells9112439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
3 Gao XY, Zang J, Zheng MH, Zhang YF, Yue KY, Cao XL, Cao Y, Li XX, Han H, Jiang XF, Liang L. Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma. Front Cell Dev Biol 2021;9:620883. [PMID: 33614649 DOI: 10.3389/fcell.2021.620883] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Saito S, Ku C, Wuputra K, Pan J, Lin C, Lin Y, Wu D, Yokoyama KK. Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application. JPM 2022;12:715. [DOI: 10.3390/jpm12050715] [Reference Citation Analysis]
5 Mukaida N, Tanabe Y, Baba T. Cancer non-stem cells as a potent regulator of tumor microenvironment: a lesson from chronic myeloid leukemia. Mol Biomed 2021;2:7. [PMID: 35006395 DOI: 10.1186/s43556-021-00030-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hassan M, Nasr SM, Elzallat M. Effect of CD133 Polymorphisms on the Risk of Developing Liver Cirrhosis and hepatocellular carcinoma Induced by Viral Hepatitis. Virus Res 2022;:198714. [PMID: 35181408 DOI: 10.1016/j.virusres.2022.198714] [Reference Citation Analysis]
7 Sun J, Liu C, Wang N, Jiang D, Zhang F, Shi J, Cheng S. All-Trans-Retinoic Acid Plus Oxaliplatin/Fluorouracil/Leucovorin for Advanced Hepatocellular Carcinoma with Pulmonary Metastasis: A Multicenter Retrospective Study. CMAR 2022;Volume 14:1663-70. [DOI: 10.2147/cmar.s354170] [Reference Citation Analysis]
8 Hsin IL, Shen HP, Chang HY, Ko JL, Wang PH. Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines. Cells 2021;10:2916. [PMID: 34831139 DOI: 10.3390/cells10112916] [Reference Citation Analysis]
9 Scioli MG, Terriaca S, Fiorelli E, Storti G, Fabbri G, Cervelli V, Orlandi A. Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives. Int J Mol Sci 2021;22:10572. [PMID: 34638913 DOI: 10.3390/ijms221910572] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ahmad E, Ali A, Nimisha, Kumar Sharma A, Apurva, Kumar A, Mehdi G, Sumayya Abdul Sattar R, Verma R, Mahajan B, Singh Saluja S. Molecular markers in cancer. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.05.029] [Reference Citation Analysis]
11 Hon KW, Zainal Abidin SA, Othman I, Naidu R. The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer. Front Pharmacol 2021;12:768861. [PMID: 34887764 DOI: 10.3389/fphar.2021.768861] [Reference Citation Analysis]
12 Wadgaonkar P, Bi Z, Wan J, Fu Y, Zhang Q, Almutairy B, Zhang W, Qiu Y, Thakur C, Hüttemann M, Chen F. Arsenic Activates the ER Stress-Associated Unfolded Protein Response via the Activating Transcription Factor 6 in Human Bronchial Epithelial Cells. Biomedicines 2022;10:967. [DOI: 10.3390/biomedicines10050967] [Reference Citation Analysis]
13 Jiang H, Yu D, Yang P, Guo R, Kong M, Gao Y, Yu X, Lu X, Fan X. Revealing the transcriptional heterogeneity of organ‐specific metastasis in human gastric cancer using single‐cell RNA Sequencing. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.730] [Reference Citation Analysis]
14 Rossi F, Noren H, Jove R, Beljanski V, Grinnemo KH. Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem Cell Res Ther 2020;11:489. [PMID: 33208173 DOI: 10.1186/s13287-020-02018-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
15 Tang L, Xiao Q, Mei Y, He S, Zhang Z, Wang R, Wang W. Insights on functionalized carbon nanotubes for cancer theranostics. J Nanobiotechnology 2021;19:423. [PMID: 34915901 DOI: 10.1186/s12951-021-01174-y] [Reference Citation Analysis]
16 Ceci C, Lacal PM, Graziani G. Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential. Pharmacol Ther 2022;236:108106. [PMID: 34990642 DOI: 10.1016/j.pharmthera.2021.108106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Koulouris A, Tsagkaris C, Messaritakis I, Gouvas N, Sfakianaki M, Trypaki M, Spyrou V, Christodoulakis M, Athanasakis E, Xynos E, Tzardi M, Mavroudis D, Souglakos J. Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies. Cancers (Basel) 2021;13:3522. [PMID: 34298740 DOI: 10.3390/cancers13143522] [Reference Citation Analysis]
18 Hu Z, Xiao D, Qiu T, Li J, Liu Z. MicroRNA-103a Curtails the Stemness of Non-Small Cell Lung Cancer Cells by Binding OTUB1 via the Hippo Signaling Pathway. Technol Cancer Res Treat 2020;19:1533033820971643. [PMID: 33174524 DOI: 10.1177/1533033820971643] [Reference Citation Analysis]
19 Cosialls E, El Hage R, Dos Santos L, Gong C, Mehrpour M, Hamaï A. Ferroptosis: Cancer Stem Cells Rely on Iron until "to Die for" It. Cells 2021;10:2981. [PMID: 34831207 DOI: 10.3390/cells10112981] [Reference Citation Analysis]
20 Zolghadr F, Bakhshinejad B, Davuchbabny S, Sarrafpour B, Seyedasli N. Critical regulatory levels in tumor differentiation: Signaling pathways, epigenetics and non-coding transcripts. Bioessays 2021;43:e2000190. [PMID: 33644880 DOI: 10.1002/bies.202000190] [Reference Citation Analysis]
21 Taweecheep P, Khine HEE, Hlosrichok A, Ecoy GAU, Sritularak B, Prompetchara E, Chanvorachote P, Chaotham C. Stemness-Suppressive Effect of Bibenzyl from Dendrobium ellipsophyllum in Human Lung Cancer Stem-Like Cells. Evid Based Complement Alternat Med 2021;2021:5516655. [PMID: 34349823 DOI: 10.1155/2021/5516655] [Reference Citation Analysis]
22 Ren C, Li J, Zhou Y, Zhang S, Wang Q. Typical tumor immune microenvironment status determine prognosis in lung adenocarcinoma. Translational Oncology 2022;18:101367. [DOI: 10.1016/j.tranon.2022.101367] [Reference Citation Analysis]
23 Sharbatoghli M, Shamshiripour P, Fattahi F, Kalantari E, Habibi Shams Z, Panahi M, Totonchi M, Asadi-lari Z, Madjd Z, Saeednejad Zanjani L. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma. J Ovarian Res 2022;15. [DOI: 10.1186/s13048-021-00921-x] [Reference Citation Analysis]
24 Sun T, Yin YF, Jin HG, Liu HR, Tian WC. Exosomal microRNA-19b targets FBXW7 to promote colorectal cancer stem cell stemness and induce resistance to radiotherapy. Kaohsiung J Med Sci 2021. [PMID: 34520626 DOI: 10.1002/kjm2.12449] [Reference Citation Analysis]
25 Aramini B, Masciale V, Arienti C, Dominici M, Stella F, Martinelli G, Fabbri F. Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments. Cancers 2022;14:2408. [DOI: 10.3390/cancers14102408] [Reference Citation Analysis]
26 Donini C, Rotolo R, Proment A, Aglietta M, Sangiolo D, Leuci V. Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective. Cells 2021;10:543. [PMID: 33806296 DOI: 10.3390/cells10030543] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Simioni C, Conti I, Varano G, Brenna C, Costanzi E, Neri LM. The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies. Front Oncol 2021;11:673506. [PMID: 34026651 DOI: 10.3389/fonc.2021.673506] [Reference Citation Analysis]
28 Gaggianesi M, Di Franco S, Pantina VD, Porcelli G, D'Accardo C, Verona F, Veschi V, Colarossi L, Faldetta N, Pistone G, Bongiorno MR, Todaro M, Stassi G. Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment. Front Oncol 2021;11:702642. [PMID: 34354950 DOI: 10.3389/fonc.2021.702642] [Reference Citation Analysis]
29 Fraser B, Peters AE, Sutherland JM, Liang M, Rebourcet D, Nixon B, Aitken RJ. Biocompatible Nanomaterials as an Emerging Technology in Reproductive Health; a Focus on the Male. Front Physiol 2021;12:753686. [PMID: 34858208 DOI: 10.3389/fphys.2021.753686] [Reference Citation Analysis]
30 Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, Chrystel I, Morandi U, Stella F, Dominici M, Haider KH. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel) 2022;14:976. [PMID: 35205721 DOI: 10.3390/cancers14040976] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
31 Hochnadel I, Hoenicke L, Petriv N, Neubert L, Reinhard E, Hirsch T, Alfonso JCL, Suo H, Longerich T, Geffers R, Lichtinghagen R, Guzmán CA, Wedemeyer H, Lenzen H, Manns MP, Bruder D, Yevsa T. Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers. Oncogene 2022. [PMID: 35173308 DOI: 10.1038/s41388-022-02222-z] [Reference Citation Analysis]
32 Margarit DH, González NS, Romanelli LM, Fendrik AJ, Scagliotti AF, Reale MV. An integrative model of cancer cell differentiation with immunotherapy. Phys Biol 2021;18. [PMID: 34633296 DOI: 10.1088/1478-3975/ac2e72] [Reference Citation Analysis]
33 Chu CN, Lee TKW. Targeting protein kinases in cancer stem cells. Essays Biochem 2022:EBC20220002. [PMID: 35607921 DOI: 10.1042/EBC20220002] [Reference Citation Analysis]
34 Masini MA, Bonetto V, Manfredi M, Pastò A, Barberis E, Timo S, Vanella VV, Robotti E, Masetto F, Andreoli F, Fiore A, Tavella S, Sica A, Donadelli M, Marengo E. Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis. Cell Mol Life Sci 2022;79:226. [PMID: 35391557 DOI: 10.1007/s00018-022-04243-z] [Reference Citation Analysis]
35 Han YS, Yi EY, Jegal ME, Kim YJ. Cancer Stem-Like Phenotype of Mitochondria Dysfunctional Hep3B Hepatocellular Carcinoma Cell Line. Cells 2021;10:1608. [PMID: 34198967 DOI: 10.3390/cells10071608] [Reference Citation Analysis]
36 Skurikhin E, Pershina O, Zhukova M, Widera D, Ermakova N, Pan E, Pakhomova A, Morozov S, Kubatiev A, Dygai A. Potential of Stem Cells and CART as a Potential Polytherapy for Small Cell Lung Cancer. Front Cell Dev Biol 2021;9:778020. [DOI: 10.3389/fcell.2021.778020] [Reference Citation Analysis]
37 DiNatale A, Kaur R, Qian C, Zhang J, Marchioli M, Ipe D, Castelli M, McNair CM, Kumar G, Meucci O, Fatatis A. Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy. Oncogene 2022. [PMID: 34999735 DOI: 10.1038/s41388-021-02174-w] [Reference Citation Analysis]
38 Stevanovic M, Kovacevic-Grujicic N, Mojsin M, Milivojevic M, Drakulic D. SOX transcription factors and glioma stem cells: Choosing between stemness and differentiation. World J Stem Cells 2021; 13(10): 1417-1445 [PMID: 34786152 DOI: 10.4252/wjsc.v13.i10.1417] [Reference Citation Analysis]
39 Yang J, Fang C, Liu H, Wu M, Tao S, Tan Q, Chen Y, Wang T, Li K, Zhong C, Zhang J. Ternary supramolecular nanocomplexes for superior anticancer efficacy of natural medicines. Nanoscale 2021;13:15085-99. [PMID: 34533154 DOI: 10.1039/d1nr02791c] [Reference Citation Analysis]
40 Hwang GR, Yuen JG, Ju J. Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development. Int J Mol Sci 2021;22:1624. [PMID: 33562727 DOI: 10.3390/ijms22041624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Li J, Fang R, Wu J, Si Y, Bai J, Wang Q. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation. Bioengineered 2022;13:7648-58. [DOI: 10.1080/21655979.2022.2050491] [Reference Citation Analysis]
42 Kazi JU. Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells. Int J Mol Sci 2020;21:E9006. [PMID: 33260802 DOI: 10.3390/ijms21239006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Tseeleesuren D, Hsiao H, Kant R, Huang Y, Tu H, Lai C, Huang S, Yen C. The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma. Medicina 2022;58:212. [DOI: 10.3390/medicina58020212] [Reference Citation Analysis]
44 Tai Y, Ma Y, Chen C, Tsai H, Tsai C, Wu M, Chen C, Lin M. Resveratrol Analog 4-Bromo-Resveratrol Inhibits Gastric Cancer Stemness through the SIRT3-c-Jun N-Terminal Kinase Signaling Pathway. CIMB 2022;44:63-72. [DOI: 10.3390/cimb44010005] [Reference Citation Analysis]
45 Wu L, Xu S, Cheng X, Zhang L, Wang Y, Wu J, Bao J, Yu H, Lu R. Capsaicin inhibits the stemness of anaplastic thyroid carcinoma cells by triggering autophagy-lysosome mediated OCT4A degradation. Phytother Res 2022. [PMID: 35076979 DOI: 10.1002/ptr.7361] [Reference Citation Analysis]
46 Zheng X, Yu C, Xu M. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy. Front Oncol 2021;11:678333. [PMID: 34262865 DOI: 10.3389/fonc.2021.678333] [Reference Citation Analysis]
47 Alghamdi MA, Fallica AN, Virzì N, Kesharwani P, Pittalà V, Greish K. The Promise of Nanotechnology in Personalized Medicine. JPM 2022;12:673. [DOI: 10.3390/jpm12050673] [Reference Citation Analysis]
48 Aramini B, Masciale V, Grisendi G, Banchelli F, D'Amico R, Maiorana A, Morandi U, Dominici M, Haider KH. Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. Oncotarget 2021;12:230-50. [PMID: 33613850 DOI: 10.18632/oncotarget.27870] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Guo J, Wang S, Han Y, Jia Z, Wang R. Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma. Oncol Lett 2021;22:554. [PMID: 34084221 DOI: 10.3892/ol.2021.12815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Parakh S, Ernst M, Poh AR. Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities. Cancers (Basel) 2021;13:6228. [PMID: 34944848 DOI: 10.3390/cancers13246228] [Reference Citation Analysis]
51 Deng S, Li L, Xu S, Wang X, Han T. Promotion of gastric tumor initiating cells in a 3D collagen gel culture model via YBX1/SPP1/NF-κB signaling. Cancer Cell Int 2021;21:599. [PMID: 34758833 DOI: 10.1186/s12935-021-02307-x] [Reference Citation Analysis]
52 Salinas-Jazmín N, Rosas-Cruz A, Velasco-Velázquez M. Reporter gene systems for the identification and characterization of cancer stem cells. World J Stem Cells 2021; 13(7): 861-876 [PMID: 34367481 DOI: 10.4252/wjsc.v13.i7.861] [Reference Citation Analysis]
53 Yang H, Cao Y, Li D, Li F, Ma J, Peng S, Liu P. AS1411 and EpDT3-conjugated silver nanotriangle-mediated photothermal therapy for breast cancer and cancer stem cells. Nanomedicine (Lond) 2021;16:2503-19. [PMID: 34812051 DOI: 10.2217/nnm-2021-0257] [Reference Citation Analysis]
54 Paterson C, Kilmister EJ, Brasch HD, Bockett N, Patel J, Paterson E, Purdie G, Galvin S, Davis PF, Itinteang T, Tan ST. Cell Populations Expressing Stemness-Associated Markers in Lung Adenocarcinoma. Life (Basel) 2021;11:1106. [PMID: 34685477 DOI: 10.3390/life11101106] [Reference Citation Analysis]
55 Stepanov YV, Golovynska I, Dziubenko NV, Kuznietsova HM, Petriv N, Skrypkina I, Golovynskyi S, Stepanova LI, Stohnii Y, Garmanchuk LV, Ostapchenko LI, Yevsa T, Qu J, Ohulchanskyy TY. NMDA receptor expression during cell transformation process at early stages of liver cancer in rodent models. Am J Physiol Gastrointest Liver Physiol 2021. [PMID: 34851733 DOI: 10.1152/ajpgi.00060.2021] [Reference Citation Analysis]
56 Carlisi D, Lauricella M, D'Anneo A, De Blasio A, Celesia A, Pratelli G, Notaro A, Calvaruso G, Giuliano M, Emanuele S. Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties. Biomedicines 2022;10:514. [PMID: 35203723 DOI: 10.3390/biomedicines10020514] [Reference Citation Analysis]
57 Habič A, Novak M, Majc B, Lah Turnšek T, Breznik B. Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment. J Histochem Cytochem 2021;:221554211035192. [PMID: 34310223 DOI: 10.1369/00221554211035192] [Reference Citation Analysis]
58 Enciso-Benavides J, Alfaro L, Castañeda-Altamirano C, Rojas N, González-Cabeza J, Enciso N, Riesco F, Castillo M, Enciso J. Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines. Heliyon 2021;7:e07273. [PMID: 34235281 DOI: 10.1016/j.heliyon.2021.e07273] [Reference Citation Analysis]
59 Wang JH, Ban LK, Lee HH, Chen YH, Lin HY, Zhu ZW, Su HY, Umezawa A, Almansour AI, Arumugam N, Kumar RS, Wu GJ, Higuchi A. Purification of Colon Carcinoma Cells from Primary Colon Tumor Using a Filtration Method via Porous Polymeric Filters. Polymers (Basel) 2021;13:3411. [PMID: 34641226 DOI: 10.3390/polym13193411] [Reference Citation Analysis]
60 Singh A, Kumar P, Sarvagalla S, Bharadwaj T, Nayak N, Coumar MS, Giri R, Garg N. Functional inhibition of c-Myc using novel inhibitors identified through “hot spot” targeting. Journal of Biological Chemistry 2022. [DOI: 10.1016/j.jbc.2022.101898] [Reference Citation Analysis]
61 Wan R, Liao H, Liu J, Zhou L, Yin Y, Mu T, Wei J, Shen Y. Development of a 5-Gene Signature to Evaluate Lung Adenocarcinoma Prognosis Based on the Features of Cancer Stem Cells. BioMed Research International 2022;2022:1-28. [DOI: 10.1155/2022/4404406] [Reference Citation Analysis]
62 Narusaka T, Ohara T, Noma K, Nishiwaki N, Katsura Y, Kato T, Sato H, Tomono Y, Kikuchi S, Tazawa H, Shirakawa Y, Matsukawa A, Fujiwara T. Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer. Int J Cancer 2021;149:347-57. [PMID: 33662150 DOI: 10.1002/ijc.33544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Bou-Rouphael J, Durand BC. T-Cell Factors as Transcriptional Inhibitors: Activities and Regulations in Vertebrate Head Development. Front Cell Dev Biol 2021;9:784998. [PMID: 34901027 DOI: 10.3389/fcell.2021.784998] [Reference Citation Analysis]
64 Keyvani V, Riahi E, Yousefi M, Esmaeili S, Shafabakhsh R, Moradi Hasan-abad A, Mahjoubin-tehran M, Hamblin MR, Mollazadeh S, Mirzaei H. Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies. Front Pharmacol 2022;13:823572. [DOI: 10.3389/fphar.2022.823572] [Reference Citation Analysis]
65 Usman S, Waseem NH, Nguyen TKN, Mohsin S, Jamal A, Teh MT, Waseem A. Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis. Cancers (Basel) 2021;13:4985. [PMID: 34638469 DOI: 10.3390/cancers13194985] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Wu L, Sun S, Qu F, Liu X, Sun M, Pan Y, Zheng Y, Su G. ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis. Front Immunol 2022;13:829640. [DOI: 10.3389/fimmu.2022.829640] [Reference Citation Analysis]
67 Loh JJ, Ma S. The Role of Cancer-Associated Fibroblast as a Dynamic Player in Mediating Cancer Stemness in the Tumor Microenvironment. Front Cell Dev Biol 2021;9:727640. [PMID: 34760886 DOI: 10.3389/fcell.2021.727640] [Reference Citation Analysis]
68 Thomas E, Thankan RS, Purushottamachar P, Huang W, Kane MA, Zhang Y, Ambulos N, Weber DJ, Njar VCO. Transcriptome profiling reveals that VNPP433-3β, the lead next-generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial-mesenchymal transition and stem cell markers. Mol Carcinog 2022. [PMID: 35512605 DOI: 10.1002/mc.23406] [Reference Citation Analysis]
69 Jardin I, Lopez JJ, Sanchez-collado J, Gomez LJ, Salido GM, Rosado JA. Store-Operated Calcium Entry and Its Implications in Cancer Stem Cells. Cells 2022;11:1332. [DOI: 10.3390/cells11081332] [Reference Citation Analysis]
70 Nicoś M, Krawczyk P. Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer. Cancers 2022;14:1813. [DOI: 10.3390/cancers14071813] [Reference Citation Analysis]
71 Boukouris AE, Zhang Y, Saleme B, Kinnaird A, Zhao YY, Liu Y, Zervopoulos SD, Das SK, Mittal RD, Haromy A, Lorenzana-Carrillo MA, Krysler AR, Cromwell CR, Hubbard BP, Sutendra G, Michelakis ED. A reversible metabolic stress-sensitive regulation of CRMP2A orchestrates EMT/stemness and increases metastatic potential in cancer. Cell Rep 2022;38:110511. [PMID: 35294884 DOI: 10.1016/j.celrep.2022.110511] [Reference Citation Analysis]
72 Yuan D, Wang J, Yan M, Xu Y. SOX2 as a prognostic marker and a potential molecular target in cervical cancer: A meta-analysis. Int J Biol Markers 2021;36:45-53. [PMID: 34719977 DOI: 10.1177/17246008211042899] [Reference Citation Analysis]